Aims: Primary percutaneous coronary intervention (PPCI) is the preferred strategy for acute ST-segment elevation myocardial infarction (STEMI),
Damian J. Kelly1, MD, MRCP; Gerald P. McCann1,2, MD, MRCP; Daniel Blackman3, MD, MRCP; Nicholas P. Curzen4, PhD, FRCP; Miles Dalby5, MD, MRCP; John P. Greenwood3, MD, MRCP; Kathryn Fairbrother1, BSc, RGN; Lorraine Shipley1, BSc, RGN; Andrew Kelion5, MD, FRCP; Simon Heatherington6, MD, MRCP; Jamal N. Khan1, MBBS; Sheraz Nazir1, MBBS; Albert Alahmar1, MBBS, MRCP; Marcus Flather7, MD, FRCP; Howard Swanton8, MD, FRCP; Peter Schofield9, MD, FRCP; Mark Gunning10, MD, FRCP; Roger Hall
1. Department of Cardiology, University Hospitals of Leicester, Leicester, United Kingdom; 2. NIHR Leicester Cardiovascular Biomedical Research Unit, Leicester, United Kingdom; 3. Department of Cardiology Jubilee Wing, Leeds General Inf
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
multivessel coronary artery diseaseprimary angioplastystemi
Read next articleLong-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients